Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
KUNLUN ENERGY
00135
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -191.78%-19.71M | ---- | 150.93%21.47M | 15.19%8.37M | -78.07%8.56M | -69.54%7.26M | -7.45%39.02M | 80.73%23.84M | 576.27%42.16M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 30.75%-286K | ---- | -8.97%-413K | ---- | -9,375.00%-379K | 0.00%-2K | 98.28%-4K | 98.68%-2K | 79.07%-233K |
| Interest expense - adjustment | ---- | 195.07%3.11M | ---- | -41.97%1.06M | -10.04%699K | -30.42%1.82M | -53.91%777K | -52.48%2.61M | -44.72%1.69M | -23.09%5.5M |
| Impairment and provisions: | ---- | -123.74%-907K | ---- | 240.25%3.82M | ---- | 364.24%1.12M | ---- | 73.65%-425K | ---- | -1,444.17%-1.61M |
| -Impairment of trade receivables (reversal) | ---- | -100.09%-1K | ---- | 1.25%1.14M | ---- | 364.24%1.12M | ---- | 73.65%-425K | ---- | -1,444.17%-1.61M |
| -Other impairments and provisions | ---- | -133.76%-906K | ---- | --2.68M | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | ---174K | ---- | ---- | ---252K | ---110K | ---- | ---- | ---- | -345.04%-593K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---174K | ---- | ---- | ---252K | ---110K | ---- | ---- | ---- | -345.04%-593K |
| Depreciation and amortization: | ---- | -12.94%49.12M | ---- | -2.26%56.42M | -4.39%28.18M | 25.22%57.72M | 28.41%29.48M | 1.34%46.1M | 2.84%22.95M | 17.55%45.49M |
| Operating profit before the change of operating capital | ---- | -62.17%31.16M | ---- | 19.82%82.36M | -1.38%36.99M | -21.27%68.73M | -22.62%37.51M | -3.76%87.3M | 26.77%48.48M | 150.29%90.71M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | 253.43%58.38M | ---- | -319.84%-38.05M | -326.63%-26.75M | 17.46%-9.06M | 159.31%11.8M | 30.25%-10.98M | -2,214.30%-19.9M | -337.49%-15.74M |
| Accounts payable increase (decrease) | ---- | -247.60%-15.51M | ---- | 91.93%10.51M | 44.59%8.21M | -68.24%5.47M | -82.53%5.68M | 53,968.75%17.24M | 140.18%32.51M | -100.93%-32K |
| Cash from business operations | ---- | 35.06%74.03M | ---- | -15.86%54.81M | -66.45%18.45M | -30.37%65.14M | -9.97%55M | 24.85%93.56M | 19.98%61.09M | 107.76%74.93M |
| Other taxs | ---- | ---1.15M | ---- | ---- | ---- | -229.81%-10.52M | -285.83%-682K | ---3.19M | --367K | ---- |
| Special items of business | -98.78%443K | ---- | --36.38M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | -98.78%443K | 32.96%72.88M | 97.14%36.38M | 0.35%54.81M | -66.02%18.45M | -39.55%54.62M | -11.62%54.31M | 20.59%90.37M | 20.70%61.46M | 90.40%74.93M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -30.75%286K | ---- | 8.97%413K | 12,500.00%252K | 9,375.00%379K | 0.00%2K | -98.28%4K | -98.68%2K | -79.07%233K |
| Decrease in deposits (increase) | ---- | 0.00%-23K | ---- | -475.00%-23K | ---- | ---4K | ---- | ---- | ---- | 85.71%-1K |
| Sale of fixed assets | ---- | --174K | ---- | ---- | ---- | --110K | ---- | ---- | ---- | 138.63%871K |
| Purchase of fixed assets | ---- | -653.35%-20.57M | ---- | 63.42%-2.73M | 88.35%-530K | -3.39%-7.47M | 5.60%-4.55M | 22.85%-7.22M | -22.19%-4.82M | -8.29%-9.36M |
| Other items in the investment business | 100.17%15K | ---- | ---8.58M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 100.17%15K | -760.19%-20.14M | -2,985.25%-8.58M | 66.46%-2.34M | 93.88%-278K | 3.27%-6.98M | 5.61%-4.55M | 12.59%-7.22M | -43.89%-4.82M | -15.12%-8.26M |
| Net cash before financing | -98.35%458K | 0.52%52.74M | 52.97%27.8M | 10.14%52.47M | -63.48%18.18M | -42.70%47.64M | -12.13%49.77M | 24.70%83.15M | 19.06%56.64M | 107.17%66.68M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | 300.00%76M | ---- | --19M | ---- | ---- |
| Refund | ---- | ---- | ---- | ---- | ---- | -3,859.98%-95M | -1,092.72%-19M | 81.71%-2.4M | 94.95%-1.59M | -127.75%-13.11M |
| Interest paid - financing | ---- | -195.07%-3.11M | ---- | 41.97%-1.06M | ---- | 30.42%-1.82M | 72.41%-8K | 52.48%-2.61M | 64.63%-29K | 23.09%-5.5M |
| Dividends paid - financing | ---- | ---20M | ---- | ---- | ---- | 16.67%-25M | ---- | ---30M | ---30M | ---- |
| Other items of the financing business | 25.26%-21.26M | ---- | ---28.44M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 25.26%-21.26M | -16.60%-58.51M | -13.35%-28.44M | 46.44%-50.18M | 42.44%-25.09M | -66.46%-93.68M | 17.83%-43.59M | -2.13%-56.28M | -65.43%-53.05M | -75.24%-55.11M |
| Net Cash | -3,169.97%-20.8M | -351.22%-5.76M | 90.80%-636K | 104.98%2.29M | -211.86%-6.91M | -271.32%-46.04M | 71.98%6.18M | 132.18%26.87M | -76.82%3.59M | 1,464.05%11.57M |
| Begining period cash | -6.78%79.23M | 2.77%84.99M | 2.77%84.99M | -35.76%82.69M | -35.76%82.69M | 26.38%128.73M | 26.38%128.73M | 12.82%101.86M | 12.82%101.86M | 0.83%90.29M |
| Cash at the end | -30.73%58.43M | -6.78%79.23M | 11.31%84.35M | 2.77%84.99M | -43.83%75.78M | -35.76%82.69M | 27.94%134.91M | 26.38%128.73M | -0.32%105.45M | 12.82%101.86M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.